Prof Sandro Porceddu
Honorary (Professorial Fellow)
The Sir Peter MacCallum Department of Oncology
271 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
C-POST study of adjuvant cemiplimab for high-risk cutaneous squamous cell carcinoma (CSCC): Disease-free survival (DFS) analyses per high-risk criteria and per start time after radiotherapy.
DOI: 10.1200/jco.2026.44.16_suppl.60832026
Journal article
Clinical and Patient-Reported Outcomes (PROs) in C-POST: Phase 3 Trial of Adjuvant Cemiplimab (Cemi) vs Placebo (Pbo) for High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
DOI: 10.1016/j.ijrobp.2026.02.1432026
Journal article
Clinical and Patient-Reported Outcomes in C-POST: Phase 3 Trial of Adjuvant Cemiplimab versus Placebo for High-Risk Cutaneous Squamous Cell Carcinoma
DOI: 10.1016/j.ejcskn.2026.1009622026
Journal article
The impact of dysphagia on carers of people with head and neck cancer: development and preliminary validation of the significant other scale for eating in head and neck cancer (SOSE-H&N)
DOI: 10.1080/09638288.2025.25945752026
Journal article
Radiation Therapy Target Objectives for Tonsillar Cancer Treated With Unilateral Radiation Therapy—a Replanning Study From TROG 12.01
DOI: 10.1016/j.ijrobp.2025.12.0582025
Research grants (ARC, NHMRC, MRFF)
Novel Treatment of Radiation Associated Dysphagia With Statins (TRADstat)
2024
Research grants (other domestic)
Next-Generation Radiotherapy Treatment Planning With Artificial Intelligence
RECENT SCHOLARLY WORKS
2026
Journal article
Comparison of Prophylactic Versus Reactive Tube Feeding Approaches on Weight Loss and Unplanned Hospital Admissions in Patients with Head and Neck Cancer Receiving Chemoradiotherapy
DOI: 10.3390/curroncol330100052026
Journal article
A deep learning approach for predicting linear accelerator output settings in automated radiotherapy planning of oligometastatic cancer
DOI: 10.1016/j.phro.2025.1008902026
Journal article
Sensorineural hearing outcomes in HPV-positive oropharyngeal cancer: a secondary analysis of the TROG 12.01 randomized trial (SHOUT)
DOI: 10.1016/j.radonc.2026.1115502025
Journal article
Étude randomisée de phase 3 comparant le cémiplimab adjuvant à un placebo et analyse des tumeurs primaires secondaires (TPS) dans le carcinome épidermoïde cutané à haut risque (CEC) : l’essai C-POST
DOI: 10.1016/j.fander.2025.09.6282025
Journal article
Radiation Therapy Utilization for Primary Cutaneous T-Cell Lymphoma Is Lowest Among Patients Living in the Most Geographically Accessible Areas: An Australian Study
DOI: 10.1016/j.ijrobp.2025.07.054